5 Cheap Small-Cap Stocks to Buy Before the Next Breakout

4. Avidity Biosciences, Inc. (NASDAQ:RNA)

Number of Hedge Fund Investors In Q2 2023: 20

Latest Share Price: $7.97

Avidity Biosciences, Inc. (NASDAQ:RNA) makes treatments for different kinds of muscular dystrophies. Analysts have rated the Strong Buy on average, with the latest coverage coming from Credit Suisse which kept an Overweight rating for the stock in August 2023.

As of June 2023, 20 hedge funds among the 910 polled by Insider Monkey were the firm’s investors. Avidity Biosciences, Inc. (NASDAQ:RNA)’s biggest hedge fund stakeholder is Peter Kolchinsky’s RA Capital Management due to its $71 million investment.

Follow Avidity Biosciences Inc. (NASDAQ:RNA)